SC 13G/A

Names of Reporting Persons

Steven D. Lebowitz

Check the Appropriate Box if a Member of a Group (See Instructions)

(a) ☐ (b) ☒

SEC Use Only

Citizenship or Place of Organization

United States

0001193125-24-025616.txt : 20240206 0001193125-24-025616.hdr.sgml : 20240206 20240206204426 ACCESSION NUMBER: 0001193125-24-025616 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 GROUP MEMBERS: ANDREW LEBOWITZ GROUP MEMBERS: ASHLEY LEBOWITZ GROUP MEMBERS: AVERY LEBOWITZ GROUP MEMBERS: DEBORAH P. LEBOWITZ GROUP MEMBERS: EMMA SALEM GROUP MEMBERS: ETHAN SALEM GROUP MEMBERS: ISLA SILVERBERG GROUP MEMBERS: KATHRYN LEBOWITZ SILVERBERG GROUP MEMBERS: KORA MIRI SILVERBERG GROUP MEMBERS: LAUREN LEBOWITZ SALEM GROUP MEMBERS: LEBOWITZ FAMILY STOCK, LLC GROUP MEMBERS: LEXI LEBOWITZ GROUP MEMBERS: OLIVIA LEBOWITZ GROUP MEMBERS: ROBERT LEBOWITZ GROUP MEMBERS: SOPHIE LEBOWITZ GROUP MEMBERS: SUSAN PEARLSTEIN GROUP MEMBERS: TAYLOR LEBOWITZ GROUP MEMBERS: ZOEY LEBOWITZ SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EBIX INC CENTRAL INDEX KEY: 0000814549 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] ORGANIZATION NAME: 06 Technology IRS NUMBER: 770021975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-38591 FILM NUMBER: 24601860 BUSINESS ADDRESS: STREET 1: 1 EBIX WAY CITY: JOHNS CREEK STATE: GA ZIP: 30097 BUSINESS PHONE: 678-281-2020 MAIL ADDRESS: STREET 1: 1 EBIX WAY CITY: JOHNS CREEK STATE: GA ZIP: 30097 FORMER COMPANY: FORMER CONFORMED NAME: EBIX COM INC DATE OF NAME CHANGE: 19991115 FORMER COMPANY: FORMER CONFORMED NAME: DELPHI INFORMATION SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LEBOWITZ STEVEN D CENTRAL INDEX KEY: 0000934389 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 439 NORTH BEDFORD DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90210 SC 13G/A 1 d758039dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

Ebix, Inc.

(Name of Issuer)

Common Stock, $0.10 par value

(Title of Class of Securities)

278715206

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	This number includes shares held by The Lebowitz Family Stock, LLC, a limited liability company of which Steven D. Lebowitz is the sole manager.

(3)

This number includes shares held by (a) Deborah P. Lebowitz, (b) The Steven & Deborah Lebowitz Foundation (the “Foundation”), a trust over which Steven D. Lebowitz serves as a co-trustee, (c) the Lebowitz Family Trust – 1986, dated October 7, 1986, as amended (the “LF Trust”), a trust over which Steven D. Lebowitz serves as a co-trustee, (d) Ethan Salem 2020 Irrevocable Trust, (e) Zoey Lebowitz 2020 Irrevocable Trust, (f) Lexi Lebowitz 2020 Irrevocable Trust, (g) Emma Salem 2020 Irrevocable Trust, (h) Kora Miri Silverberg 2021 Irrevocable Trust, (i) Isla Silverberg 2020 Irrevocable Trust, (j) Olivia Lebowitz 2020 Irrevocable Trust, (k) Sophie Lebowitz 2020 Irrevocable Trust, (l) Avery Lebowitz 2020 Irrevocable Trust, and (m) Taylor Lebowitz 2020 Irrevocable Trust.

(4)	This number includes shares held by (a) Lauren Lebowitz Salem, (b) Robert Lebowitz, (c) Kathryn Lebowitz Silverberg, (d) the A&A Lebowitz Trust (the “AA Trust”), and (e) Susan Pearlstein.

(5)	Based on 30,901,440 shares of common stock of Ebix, Inc. (the “Issuer”) outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)

This number includes shares held by (a) the Foundation, a trust over which Deborah P. Lebowitz serves as a co-trustee, (b) the LF Trust, a trust over which Deborah P. Lebowitz serves as a co-trustee, (c) Ethan Salem 2020 Irrevocable Trust, (d) Zoey Lebowitz 2020 Irrevocable Trust, (e) Lexi Lebowitz 2020 Irrevocable Trust, (f) Emma Salem 2020 Irrevocable Trust, (g) Kora Miri Silverberg 2021 Irrevocable Trust, (h) Isla Silverberg 2020 Irrevocable Trust, (i) Olivia Lebowitz 2020 Irrevocable Trust, (j) Sophie Lebowitz 2020 Irrevocable Trust, (k) Avery Lebowitz 2020 Irrevocable Trust, and (l) Taylor Lebowitz 2020 Irrevocable Trust.

(3)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	This number includes shares held by the AA Trust, a trust over which Andrew Lebowitz serves as a co-trustee.

(3)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	This number includes shares held by the AA Trust, a trust over which Ashley Lebowitz serves as a co-trustee.

(3)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.

CUSIP No. 278715206

(1)	The number of shares reported as beneficially owned as of December 31, 2023.

(2)	Based on 30,901,440 shares of common stock of the Issuer outstanding as of November 8, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the U.S. Securities and Exchange Commission on November 14, 2023.


Item 1.
	(a)	Name of Issuer Ebix, Inc.

	(b)	Address of Issuer’s Principal Executive Offices 1 Ebix Way Johns Creek, Georgia 30097

Item 2.

	(a)	Name of Person Filing Steven D. Lebowitz, Deborah P. Lebowitz, Lauren Lebowitz Salem, Robert Lebowitz, Kathryn Lebowitz Silverberg, Andrew Lebowitz, Ashley Lebowitz, The Lebowitz Family Stock, LLC, Susan Pearlstein, Ethan Salem, Zoey Lebowitz, Lexi Lebowitz, Emma Salem, Kora Miri Silverberg, Isla Silverberg, Olivia Lebowitz, Sophie Lebowitz, Avery Lebowitz, and Taylor Lebowitz (collectively, the “Reporting Persons”). The Reporting Persons have entered into a Joint Filing Agreement, which is attached hereto as Exhibit 99.1, pursuant to which the Reporting Persons have agreed to file this statement and any subsequent amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.

	(b)	Address of Principal Business Office or, if none, Residence 1333 Second Street, Suite 650 Santa Monica, CA 90401

	(c)	Citizenship See responses to Item 4 on each cover page.

	(d)	Title of Class of Securities Common Stock

	(e)	CUSIP Number 278715206

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	☐	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

	(b)	☐	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

	(c)	☐	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

	(d)	☐	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

	(e)	☐	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);



	(f)	☐	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

	(g)	☐	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

	(h)	☐	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

	(i)	☐	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

	(j)	☐	A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);

	(k)	☐	Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:____________________________

Item 4.	Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

	(a)	Amount beneficially owned: See responses to Item 9 on each cover page.

	(b)	Percent of class: See responses to Item 11 on each cover page.

	(c)	Number of shares as to which the person has:

		(i)	Sole power to vote or to direct the vote See responses to Item 5 on each cover page.

		(ii)	Shared power to vote or to direct the vote See responses to Item 6 on each cover page.

		(iii)	Sole power to dispose or to direct the disposition of See responses to Item 7 on each cover page.

		(iv)	Shared power to dispose or to direct the disposition of See responses to Item 8 on each cover page.

Item 5.	Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable.

Item 8.

Identification and Classification of Members of the Group

Please see attached the statement in Exhibit 99.2.

Item 9.

Notice of Dissolution of Group

Not applicable.

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 6, 2024


Steven D. Lebowitz		Andrew Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Deborah P. Lebowitz		Ashley Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Lauren Lebowitz Salem		The Lebowitz Family Stock, LLC

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Robert Lebowitz		Susan Pearlstein

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Kathryn Lebowitz Silverberg		Ethan Salem

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Zoey Lebowitz		Lexi Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Emma Salem		Kora Miri Silverberg

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Isla Silverberg		Olivia Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Sophie Lebowitz		Avery Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact


Taylor Lebowitz

By:		/s/ Andrew Collins
		Andrew Collins, Attorney-In-Fact

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

EXHIBIT INDEX


Exhibit 99.1		Joint Filing Agreement

Exhibit 99.2		Item 8 Statement

Exhibit 99.3		Power of Attorney (Incorporated by reference to Exhibit 99.3 to the Reporting Persons’ Schedule 13G, filed with the U.S. Securities and Exchange Commission on March 29, 2021.)**

Exhibit 99.4		Power of Attorney

**	Previously filed.

EX-99.1 2 d758039dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Joint Filing Agreement

February 6, 2024

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, of a statement on Schedule 13G (including amendments, restatements, supplements and/or exhibits thereto) with respect to Common Stock, $0.10 par value per share, of Ebix, Inc..


Ethan Salem 2020 Irrevocable Trust		Zoey Lebowitz 2020 Irrevocable Trust

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Lexi Lebowitz 2020 Irrevocable Trust		Emma Salem 2020 Irrevocable Trust

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Kora Miri Silverberg 2021 Irrevocable Trust		Isla Silverberg 2020 Irrevocable Trust

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Olivia Lebowitz 2020 Irrevocable Trust		Sophie Lebowitz 2020 Irrevocable Trust

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Avery Lebowitz 2020 Irrevocable Trust		Taylor Lebowitz 2020 Irrevocable Trust

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Steven D. Lebowitz		Andrew Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Deborah P. Lebowitz		Ashley Lebowitz

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Lauren Lebowitz Salem		The Lebowitz Family Stock, LLC

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Robert Lebowitz		Susan Pearlstein

By:	/s/ Andrew Collins	By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact		Andrew Collins, Attorney-In-Fact

Kathryn Lebowitz Silverberg

By:	/s/ Andrew Collins
	Andrew Collins, Attorney-In-Fact

EX-99.2 3 d758039dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

Item 8 Statement

Due to the relationships amongst them, all of the Reporting Persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

EX-99.4 4 d758039dex994.htm EX-99.4 EX-99.4

Exhibit 99.4

POWER OF ATTORNEY

February 5, 2024

Each of the undersigned hereby constitutes and appoints each of Steven D. Lebowitz and Andrew Collins as the undersigned’s true and lawful authorized representative and attorney-in-fact to execute for, and on behalf of, the undersigned and to file with the U.S. Securities and Exchange Commission and any other authority: (1) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16(a) of the Securities and Exchange Act of 1934, as amended (the “1934 Act”), and the rules promulgated thereunder; and (2) any Schedules 13D and Schedules 13G, and any amendments thereto, in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder, in each case with respect to any securities of Ebix, Inc. (and any successor thereto).

Each of the undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, hereby ratifying and confirming all that each such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. Each of the undersigned acknowledges that each of the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 or any other provision of the 1934 Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Forms 3, 4 and 5 or Schedules 13D or Schedules 13G with respect to any securities of Ebix, Inc. (or any successor thereto), unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned have caused this Power of Attorney to be executed as of the date first written above.


Ethan Salem 2020 Irrevocable Trust		Zoey Lebowitz 2020 Irrevocable Trust

By:	/s/ Steven D. Lebowitz	By:	/s/ Steven D. Lebowitz
Name: Steven D. Lebowitz		Name: Steven D. Lebowitz
Title: Authorized Signatory		Title: Authorized Signatory

Lexi Lebowitz 2020 Irrevocable Trust		Emma Salem 2020 Irrevocable Trust

By:	/s/ Steven D. Lebowitz	By:	/s/ Steven D. Lebowitz
Name: Steven D. Lebowitz		Name: Steven D. Lebowitz
Title: Authorized Signatory		Title: Authorized Signatory

Kora Miri Silverberg 2021 Irrevocable Trust		Isla Silverberg 2020 Irrevocable Trust

By:	/s/ Steven D. Lebowitz	By:	/s/ Steven D. Lebowitz
Name: Steven D. Lebowitz		Name: Steven D. Lebowitz
Title: Authorized Signatory		Title: Authorized Signatory

Olivia Lebowitz 2020 Irrevocable Trust		Sophie Lebowitz 2020 Irrevocable Trust

By:	/s/ Steven D. Lebowitz	By:	/s/ Steven D. Lebowitz
Name: Steven D. Lebowitz		Name: Steven D. Lebowitz
Title: Authorized Signatory		Title: Authorized Signatory

Avery Lebowitz 2020 Irrevocable Trust		Taylor Lebowitz 2020 Irrevocable Trust

By:	/s/ Steven D. Lebowitz	By:	/s/ Steven D. Lebowitz
Name: Steven D. Lebowitz		Name: Steven D. Lebowitz
Title: Authorized Signatory		Title: Authorized Signatory